HHV‐8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions
Transplant Infectious Disease · 2026
DOI: 10.1111/tid.70179 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transplant Infectious Disease, 2026. Verfasst von Alessandra Mularoni und 9 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS ISMETT, Palermo, Italy. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Organ Transplantation, Sarcoma, Kaposi, Herpesviridae Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, National Recovery and Resilience Plan, Mission 4.
Abstract (Originalsprache)
The incidence of HHV‐8/KSHV–associated diseases (KADs) among solid organ transplant (SOT) recipients has shown a relative increase, likely reflecting the growing population of long‐term SOT survivors and heightened recognition and reporting due to greater clinician awareness. The real impact of HHV‐8/KSHV in the SOT setting remains difficult to determine due to regional variations in seroprevalence and non‐universal screening practices. Neoplastic KAD reported in SOT includes Kaposi sarcoma (KS), multicentric Castleman disease (MCD), primary effusion lymphoma (PEL), and other rare lymphomas. Increasing attention has focused on Kaposi's Sarcoma‐associated Herpesvirus Inflammatory Cytokine Syndrome (KICS), a non‐malignant syndrome characterized by uncontrolled inflammation, fever, pancytopenia and elevated HHV‐8/KSHV DNAemia, resembling viral sepsis that can progress to shock and multi‐organ failure. A clinical protocol including testing donors and recipients, monitoring for DNAemia in recipients at risk, switching CNI to mTOR inhibitors, treatment with antivirals, and rituximab for KICS may mitigate the impact of HHV‐8/KSHV infection in SOT recipients. However, standardized serological testing is not available and the role of monitoring, preemptive management and treatment of HHV‐8/KSHV DNAemia should be studied in larger prospective studies. Severe donor‐derived KICS and KS, often presenting without skin involvement, underscore the need for reliable serologic tests for identification of at‐risk recipients (especially D+/R‐), heightened clinical awareness to ensure timely diagnosis and prompt treatment. This review provides an updated overview of KADs with a particular focus on KICS in SOT, highlights knowledge gaps for future research, and summarizes recent advances in the screening and management of HHV‐8/KSHV infection following transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS ISMETT, Palermo, Italy.
- UPMC Italy, Palermo, Italy.
- Division of Infectious Diseases, Department of Health Sciences, University of Genoa, Genoa, Italy.
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
- Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
- Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
ORCID-Profile: Alessandra Mularoni, Andrea Cona
Förderung
- Italian Ministry of Health
- National Recovery and Resilience Plan, Mission 4
Zitieren
APA
Mularoni, A., Cona, A., Mikulska, M., Pecoraro, F., Piazza, C., De Vita, E., Pietrosi, G., Bulati, M., Lazzarotto, T., & Luppi, M. (2026). HHV‐8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions. Transplant Infectious Disease. https://doi.org/10.1111/tid.70179
Vancouver
Mularoni A, Cona A, Mikulska M, Pecoraro F, Piazza C, De Vita E, et al. HHV‐8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions. Transplant Infectious Disease. 2026. doi:10.1111/tid.70179
BibTeX
@article{Mularoni2026,
author = {Mularoni, Alessandra and Cona, Andrea and Mikulska, Malgorzata and Pecoraro, Francesca and Piazza, Carlotta and De Vita, Elda and Pietrosi, Giada and Bulati, Matteo and Lazzarotto, Tiziana and Luppi, Mario},
title = {HHV‐8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions},
journal = {Transplant Infectious Disease},
year = {2026},
doi = {10.1111/tid.70179}
}
EUVIMED